Advertisement

Breathlessness and Weight Loss

  • Sowmya ShashidharaEmail author
  • H. Koushik
  • Sangita Trivedi
Chapter

Abstract

  • Patients presenting with disproportionate hypoxia and pneumonia unresponsive to conventional antibiotics have a high index of suspicion for Pneumocystis pneumonia

  • Pneumocystis jirovecii pneumonia is an AIDS-defining infection

  • Placental macrophages and CD195 receptors are implicated in the pathogenesis of HIV

  • Prompt initiation of highly active anti-retroviral therapy (HAART) therapy can resolve cryptosporidiosis infection in patients with HIV, even with no antibiotic therapy

  • Exclusion of HIV infection is possible with antibody testing after at least 3 months of cessation of breastfeeding

  • Evaluation of side effects of anti-retroviral therapy is necessary during follow-ups

Keywords

Highly active anti-retroviral therapy AIDS Pneumocystis jirovecii 

References

  1. 1.
    World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2nd ed. Geneva: World Health Organization; 2016.Google Scholar
  2. 2.
    Muenchhoff M, Prendergast AJ, Goulder PJR. Immunity to HIV in early life. Front Immunol. 2014;5:1–13.CrossRefGoogle Scholar
  3. 3.
    Bunders MJ, van der Loos CM, Klarenbeek PL, van Hamme JL, Boer K, Wilde JC, de Vries N, van Lier RA, Kootstra N, Pals ST, Kuijpers TW. Memory CD4(+)CCR5(+) T cells are abundantly present in the gut of newborn infants to facilitate mother-to-child transmission of HIV-1. Blood. 2012;120(22):4383–90.CrossRefGoogle Scholar
  4. 4.
    Chang JJ, Altfeld M. TLR-mediated immune activation in HIV. Blood. 2009;113(2):269–70.CrossRefGoogle Scholar
  5. 5.
    Swann SA, Williams M, Story CM, Bobbitt KR, Fleis R, Collins KL. HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway. Virology. 2001;282(2):267–77.CrossRefGoogle Scholar
  6. 6.
    Johnson EL, Chakraborty R. HIV-1 at the placenta: immune correlates of protection and infection. Curr Opin Infect Dis. 2016;29(3):248–55.CrossRefGoogle Scholar
  7. 7.
    Abubakar I, Aliyu SH, Arumugam C, Usman NK, Hunter PR. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol. 2007;63(4):387–93.CrossRefGoogle Scholar
  8. 8.
    World Health Organization. WHO recommendations on the management of diarrhoea and pneumonia in HIV-infected infants and children. 1st ed. Geneva: WHO Press, World Health Organization; 2010.Google Scholar
  9. 9.
    World Health Organisation. WHAT’S new in infant diagnosis. Geneva: World Health Organisation; 2015.Google Scholar
  10. 10.
    World Health Organisation. WH Guidelines on the Treatment of Skin and Oral HIV-Associated Conditions in Children and Adults. Geneva: World Health Organization; 2014. Annex 1, ART recommendations. https://www.ncbi.nlm.nih.gov/books/NBK305414/. Accessed 09/18/2016.

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Sowmya Shashidhara
    • 1
    • 2
    Email author
  • H. Koushik
    • 1
  • Sangita Trivedi
    • 3
  1. 1.Department of Pediatrics, Kasturba Medical CollegeManipal UniversityManipalIndia
  2. 2.Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN)ManipalIndia
  3. 3.Department of Pediatrics, Government Medical CollegeVeer Narmad South Gujarat UniversitySuratIndia

Personalised recommendations